Top Story

Rivaroxaban reduced VTE recurrence, major bleeding in patients with cancer

September 28, 2014

Rivaroxaban demonstrated comparable efficacy and a better safety profile compared with standard therapy in patients with venous thromboembolism and cancer, according to a pooled subgroup analysis of two randomized trials.

Patients with cancer and venous thromboembolism (VTE) are at considerable risk for VTE recurrence and bleeding while they undergo therapy with anticoagulants. Monotherapy with low–molecular-weight heparin is recommended for these patients, but many do not receive this treatment in the clinical setting, according to background information provided by researchers.

figure

HHS aims to prevent chronic disease with $212 million in grant awards

September 26, 2014
HHS Secretary Sylvia M. Burwell announced that nearly $212 million in grants will be awarded across all 50 states and the District of Columbia in support of programs…
In the Journals

No source of Herbaspirillum spp. identified in cluster of patients

September 26, 2014
No environmental or common source was identified as the cause of Herbaspirillum spp. infections among a cluster eight patients with cancer receiving care at The…
Institution Notes

St. Jude announces faculty appointments

HemOnc Today, September 25, 2014
St. Jude Children’s Research Hospital officials announced the appointment of two internationally recognized physician–scientists to leadership positions.Mitchell Weiss
CME
figure

Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC

This activity is supported by an educational grant from Genentech, Inc.

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, but the numerous subtypes make this disease…
More »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »

Filter By:

Meeting News Coverage

Rivaroxaban reduced VTE recurrence, major bleeding in patients with cancer

September 28, 2014
Rivaroxaban demonstrated comparable efficacy and a better safety profile compared with standard therapy in patients with venous thromboembolism and…
figure

HHS aims to prevent chronic disease with $212 million in grant awards

September 26, 2014
HHS Secretary Sylvia M. Burwell announced that nearly $212 million in grants will be awarded across all 50 states and the District of Columbia in…
In the Journals

No source of Herbaspirillum spp. identified in cluster of patients

September 26, 2014
No environmental or common source was identified as the cause of Herbaspirillum spp. infections among a cluster eight patients with cancer receiving…
Institution Notes

St. Jude announces faculty appointments

HemOnc Today, September 25, 2014
St. Jude Children’s Research Hospital officials announced the appointment of two internationally recognized physician–scientists to leadership…
figure Editorial Publication Exclusive

I’d like to agree with you … but then we’d both be wrong!

HemOnc Today, September 25, 2014
Derek Raghavan, MD, PhD
I sometimes fear that I am a natural curmudgeon, or at the very least a true cynic.If you have read my recent editorials and op-eds, it may seem I…
Meeting News Coverage

TEDMED: Sensor technology helps test hands-on skills

September 22, 2014
After witnessing a colleague miss a blood clot in a patient with acute coronary syndrome, Carla M. Pugh, MD, PhD, FACS, recognized the need for a…

NIH director: Emerging biomedical research ‘breathtaking’

September 19, 2014
NIH director Francis Collins, MD, PhD, spoke to the audience at TEDMED 2014 about the advances in biomedical research on the horizon.“I have…
Industry News

PCORI opens comment period on peer review, release of research findings draft

September 18, 2014
The Patient-Centered Outcomes Research Institute approved its draft proposal process for peer review and public release of primary research findings…
figure Meeting News Coverage

Single-fraction radiation effective for bone metastases

September 17, 2014
Patients with bone metastases who underwent single-fraction palliative radiation therapy reported similar improvements in pain, function and distress…
figure Meeting News Coverage

Shorter ADT regimen improved quality of life among men with high-risk prostate cancer

September 16, 2014
Men with high-risk prostate cancer who underwent treatment with radiotherapy plus 18 months of androgen deprivation therapy demonstrated improved…
More Headlines »